Please login to the form below

Not currently logged in
Email:
Password:

Santarus adds two board members

Alessandro Della Chà and Dr Matthew Strobeck join US biopharma

Santarus has appointed Alessandro Della Chà and Dr Matthew Strobeck to its board of directors.

The appointments mean the US-based biopharma firm, which has products including Glumetza (metformin hydrochloride extended release tablets) and Cycloset (bromocriptine mesylate) tablets, has now increased its number of directors to nine.

“We welcome our new board members and look forward to drawing on their industry, business and corporate expertise as we continue to build Santarus into a premier specialty biopharmaceutical company,” said David Hale, chair of Santarus.

Della Chà has been a senior partner of Italian commercial law firm Studio Legale Edoardo Ricci e Associati, since 1997. He has also been co-managing director of the company since 2003. He currently also serves as a director of Cosmo Pharmaceuticals.

Dr Strobeck was a partner, member of the management committee and member of the advisory board of Westfield Capital Management from 2008 to 2011. He currently serves as a member of the board of directors of Metabolix.

11th April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics